A Review on Adverse Drug Reaction in Pharmacovigilance

Author:

Ms. Bhore Shruti 1,Ms. Saniya Pathan 1,Ms. Gadge Rutuja 1,Mr. Tambe Sagar 1

Affiliation:

1. Samarth Institute of Pharmacy, Belhe, Pune, Maharashtra, India

Abstract

Pharmacovigilance is a practice aimed to monitor drug safety in real life conditions and capture adverse drug events during the post marketing phase of drug's life cycle. But under reporting of adverse reactions is a major cause of concern and a threat to the pharmacovigilance systems. The present article looks into the major obstacles affecting the spontaneous reporting of adverse drug reactions (ADRs) in India and the possible solutions. As per available scientific literature, the major impediments to ADR reporting are inadequate knowledge and awareness among health professionals, clinicians' perceptions towards reporting, problems with establishing reporting systems in hospitals and insufficient training to recognize ADRs. Measures to improve the situation include greater involvement of nurses, pharmacists as well as consumers in the reporting of ADRs, making the process simpler and faster through electronic means, introducing educational interventions and training programs for health care providers and spreading awareness about the reporting system amongst caregivers and receivers alike. Providing a momentum to the pharmacovigilance system and ensuring a robust reporting process is a challenge but proper planning, feasible solutions and focussed efforts can help bring about the change ensuring patient safety - the ultimate goal of pharmacovigilance.

Publisher

Naksh Solutions

Subject

General Medicine

Reference12 articles.

1. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356: 1255–1259. [PubMed] [Google Scholar]

2. World Health Organization. Safety of medicines. A guide to detecting and reporting adverse drug reactions – why health professionals need to take action. Geneva: World Health Organization; 2002. [Google Scholar]

3. World Health Organization . Safety monitoring of medicinal products: guidelines for setting up and running a pharmacovigilance centre. Uppsala: Uppsala Monitoring Centre, World Health Organization; 2000. [Google Scholar]

4. Routledge P. 150 years of pharmacovigilance. Lancet. 1998;351:1200–1201. [PubMed] [Google Scholar]

5. Van Grootheest K. The dawn of pharmacovigilance. Intern J Pharm Med. 2003;17:195–200. [Google Scholar]

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3